DocGo Inc. (NASDAQ:DCGO - Get Free Report) saw a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 6,540,000 shares, a decline of 15.2% from the February 28th total of 7,710,000 shares. Based on an average daily trading volume, of 818,200 shares, the days-to-cover ratio is presently 8.0 days. Approximately 7.5% of the shares of the company are sold short.
Institutional Investors Weigh In On DocGo
A number of hedge funds have recently made changes to their positions in DCGO. Centiva Capital LP acquired a new position in shares of DocGo in the 3rd quarter worth approximately $43,000. Summit Investment Advisors Inc. boosted its stake in DocGo by 38.7% in the fourth quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock worth $45,000 after purchasing an additional 2,968 shares in the last quarter. Prudential Financial Inc. bought a new stake in shares of DocGo during the fourth quarter worth $55,000. Intech Investment Management LLC acquired a new stake in shares of DocGo in the third quarter valued at $62,000. Finally, Royce & Associates LP bought a new position in shares of DocGo in the fourth quarter valued at about $64,000. Institutional investors and hedge funds own 56.44% of the company's stock.
DocGo Trading Down 2.0 %
NASDAQ DCGO traded down $0.05 on Friday, reaching $2.51. The company's stock had a trading volume of 1,287,990 shares, compared to its average volume of 763,046. DocGo has a 52 week low of $2.44 and a 52 week high of $5.68. The firm has a market cap of $255.98 million, a PE ratio of 8.96, a price-to-earnings-growth ratio of 14.16 and a beta of 1.12. The business has a 50-day moving average price of $3.85 and a 200 day moving average price of $3.88.
Analysts Set New Price Targets
Several research firms recently commented on DCGO. Stifel Nicolaus cut their target price on shares of DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a research note on Friday, February 28th. Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a "buy" rating to a "hold" rating and cut their price objective for the company from $5.00 to $2.85 in a research report on Friday, February 28th. Finally, Needham & Company LLC decreased their target price on DocGo from $7.00 to $4.00 and set a "buy" rating on the stock in a research report on Friday, February 28th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, DocGo has a consensus rating of "Moderate Buy" and an average price target of $4.89.
Read Our Latest Report on DocGo
About DocGo
(
Get Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
See Also
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
